220353-22-0

Basic information

• Product Name: 4-AMINO-2,6-DIFLUOROPHENOL
• Synonyms: 4-Amino-2,6-difluorophenol hydrochloride;4-amino-2,6-difluorophenol.HCl;3,5-Difluoro-4-hydroxyaniline (hydrochloride)
• CAS NO: 220353-22-0
• Molecular Formula: C6H5F2NO
• Molecular Weight: 0
• Mol File: 220353-22-0.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 237°C at 760 mmHg
• Flash Point: 97.1°C
• Appearance: /
• Vapor Pressure: 0.0299mmHg at 25°C
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 4-AMINO-2,6-DIFLUOROPHENOL(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINO-2,6-DIFLUOROPHENOL(220353-22-0)
• EPA Substance Registry System: 4-AMINO-2,6-DIFLUOROPHENOL(220353-22-0)

Safety Data

• Hazardous Substances Data: 220353-22-0(Hazardous Substances Data)

Usage

Uses

4-Amino-2,6-difluorophenol, HCl

InChI:InChI=1/C6H5F2NO.ClH/c7-4-1-3(9)2-5(8)6(4)10;/h1-2,10H,9H2;1H

Upstream product

• 658-07-1 2,6-Difluoro-4-nitrophenol 
• 66684-58-0 3,4,5-trifluoronitrobenzene 

Relevant articles and documents

SUBSTITUTED PYRROLOPYRIDINE-DERIVATIVES

The present invention relates to protein-inhibitory substituted pyrrolopyridine derivatives of formula (I) in which A, X, R1a, R1b, R2, R3a, R3b, R4a and R4b are as defined herein, to pharmaceutical compositions and combinations comprising the compounds according to the invention, and to the prophylactic and therapeutic use of the inventive compounds, respectively to the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular for neoplastic disorders, repectively cancer or conditions with dysregulated immune responses or other disorders associated with aberrant MAP4K1 signaling, as a sole agent or in combination with other active ingredients. The present invention further relates to the use, respectively to the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of protein inhibitors in benign hyperplasias, atherosclerotic disorders, sepsis, autoimmune disorders, vascular disorders, viral infections, in neurodegenerative disorders, in inflammatory disorders, in atherosclerotic disorders and in male fertility control.